Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart failure in women: could a social worker be the missing prescription?

NCT ID NCT06628973

Disease control Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether social prescribing—connecting patients to community resources for issues like housing, income, or loneliness—can help women with heart failure better adhere to their medications and improve their quality of life. Researchers will enroll 200 women across five Canadian centers who have heart failure and face social challenges. Half will receive standard care, while the other half will work with a link worker to get personalized social prescriptions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
social prescribing (link worker referrals to community services)
What this could lead to
If it works, this could show that addressing social needs like housing or transportation helps women with heart failure stick to their medications and feel better.
What could go wrong
This is a relatively small, early-stage trial (200 participants) testing a behavioral intervention, so results may not apply broadly. The effect on clinical outcomes like hospitalizations is not directly measured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women * 18 years of age or older * Documented HF of any etiology * Valid personal health identifier * Two or more points on the weighted SPARK questionnaire Exclusion Criteria: * Patients not meeting inclusion criteria * Do not take HF medications * Not residents of the province where they are being followed or who have opted out from their provincial health registry * Patients with severe cognitive impairment or other conditions that significantly impact the ability to participate in SP will also be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coitus congestive heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac failure Congestive heart failure(CHF) Heart decompensation Heart failure Myocardial failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Research Institute of the McGill University Health Centre

    NOT_YET_RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Royal Victoria Hospital

    RECRUITING

    Montreal, Quebec, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.